CYCLOSPORINE-ASSOCIATED CENTRAL NERVOUS SYSTEM TOXICITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION

Authors:
  • KAKerry Atkinson
    Kerry Atkinson
  • JBJames Biggs
    James Biggs
  • PDPaul Darveniza
    Paul Darveniza
  • JBJohn Boland
    John Boland
  • ACAlan Concannon
    Alan Concannon
  • ADAnthony Dodds
    Anthony Dodds

Abstract
Five of 64 recipients of HLA-identical sibling marrow allografts who were given cyclosporin (CSP) to minimize graft-versus-host disease posttransplant had a serious neurological illness thought to be due to CSP. Characteristic clinical features included a motor spinal cord syndrome, a cerebellar-like syndrome, and mental confusion. All five recovered when the CSP dose was reduced or the drug was stopped.